SOMAmer | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

81 results for “SOMAmer”

Trials

View all 53 →

Korean Regulatory Post Marketing Surveillance for Somavert

11 participants · First posted Nov 23, 2021

Long Term Use of Somavert (Pegvisomant) For A Regulatory Post Marketing Commitment Plan

251 participants · First posted Apr 15, 2008

Healthy Summer Learners

180 participants · First posted Oct 25, 2017

Drugs

Dual VEGF/PDGF-B-targeting SOMAmers (SomaLogic)

SomaDex

Organizations

Iris Sommer

Germany

Faraj Samer

Israel

MEDTRONIC SOFAMOR DANEK, CO., LTD.

Japan

News

View all 22 →

Standard BioTools' SomaScan Platform Selected for Singapore's Landmark 100,000-Sample Precision Medicine Study

Illumina Launches Protein Prep Assay to Accelerate Drug Discovery Through Large-Scale Proteomics

Pre-Travel Health Planning Essential as Summer Travel Surges, Experts Warn

Page 1 of 9